microRNAs as a New Mechanism Regulating Adipose Tissue Inflammation in Obesity and as a Novel Therapeutic Strategy in the Metabolic Syndrome
Obesity is associated closely with the metabolic syndrome (MS). It is well known that obesity-induced chronic inflammation plays a fundamental role in the pathogenesis of MS. White adipose tissue (AT) is the primary site for the initiation and exacerbation of obesity-associated inflammation. Explori...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2014/987285 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832567394894086144 |
---|---|
author | Qian Ge Sonia Brichard Xu Yi QiFu Li |
author_facet | Qian Ge Sonia Brichard Xu Yi QiFu Li |
author_sort | Qian Ge |
collection | DOAJ |
description | Obesity is associated closely with the metabolic syndrome (MS). It is well known that obesity-induced chronic inflammation plays a fundamental role in the pathogenesis of MS. White adipose tissue (AT) is the primary site for the initiation and exacerbation of obesity-associated inflammation. Exploring the mechanisms of white AT inflammation and resetting the immunological balance in white AT could be crucial for the management of MS. Several prominent molecular mechanisms have been proposed to mediate inflammation in white AT, including hypoxia, endoplasmic reticulum stress, lipotoxicity, and metabolic endotoxemia. Recently, a growing body of evidence supports the role of miRNAs as a new important inflammatory mediator by regulating both the adaptive and innate immunity. This review will focus on the implication of miRNAs in white AT inflammation in obesity, and will also highlight the potential of miRNAs as targets for therapeutic intervention in MS as well as the challenges lying in miRNA-targeting therapeutics. |
format | Article |
id | doaj-art-a796d5eac00740afb68bd2c8be105162 |
institution | Kabale University |
issn | 2314-8861 2314-7156 |
language | English |
publishDate | 2014-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Immunology Research |
spelling | doaj-art-a796d5eac00740afb68bd2c8be1051622025-02-03T01:01:44ZengWileyJournal of Immunology Research2314-88612314-71562014-01-01201410.1155/2014/987285987285microRNAs as a New Mechanism Regulating Adipose Tissue Inflammation in Obesity and as a Novel Therapeutic Strategy in the Metabolic SyndromeQian Ge0Sonia Brichard1Xu Yi2QiFu Li3Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, ChinaEndocrinology, Diabetes and Nutrition Unit, Institute of Experimental and Clinical Research, Medical Sector, University of Louvain, 1200 Brussels, BelgiumNeurology Unit, Daping Hospital, Research Institute of Surgery, The Third Military Medical University, Chongqing 400042, ChinaDepartment of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, ChinaObesity is associated closely with the metabolic syndrome (MS). It is well known that obesity-induced chronic inflammation plays a fundamental role in the pathogenesis of MS. White adipose tissue (AT) is the primary site for the initiation and exacerbation of obesity-associated inflammation. Exploring the mechanisms of white AT inflammation and resetting the immunological balance in white AT could be crucial for the management of MS. Several prominent molecular mechanisms have been proposed to mediate inflammation in white AT, including hypoxia, endoplasmic reticulum stress, lipotoxicity, and metabolic endotoxemia. Recently, a growing body of evidence supports the role of miRNAs as a new important inflammatory mediator by regulating both the adaptive and innate immunity. This review will focus on the implication of miRNAs in white AT inflammation in obesity, and will also highlight the potential of miRNAs as targets for therapeutic intervention in MS as well as the challenges lying in miRNA-targeting therapeutics.http://dx.doi.org/10.1155/2014/987285 |
spellingShingle | Qian Ge Sonia Brichard Xu Yi QiFu Li microRNAs as a New Mechanism Regulating Adipose Tissue Inflammation in Obesity and as a Novel Therapeutic Strategy in the Metabolic Syndrome Journal of Immunology Research |
title | microRNAs as a New Mechanism Regulating Adipose Tissue Inflammation in Obesity and as a Novel Therapeutic Strategy in the Metabolic Syndrome |
title_full | microRNAs as a New Mechanism Regulating Adipose Tissue Inflammation in Obesity and as a Novel Therapeutic Strategy in the Metabolic Syndrome |
title_fullStr | microRNAs as a New Mechanism Regulating Adipose Tissue Inflammation in Obesity and as a Novel Therapeutic Strategy in the Metabolic Syndrome |
title_full_unstemmed | microRNAs as a New Mechanism Regulating Adipose Tissue Inflammation in Obesity and as a Novel Therapeutic Strategy in the Metabolic Syndrome |
title_short | microRNAs as a New Mechanism Regulating Adipose Tissue Inflammation in Obesity and as a Novel Therapeutic Strategy in the Metabolic Syndrome |
title_sort | micrornas as a new mechanism regulating adipose tissue inflammation in obesity and as a novel therapeutic strategy in the metabolic syndrome |
url | http://dx.doi.org/10.1155/2014/987285 |
work_keys_str_mv | AT qiange micrornasasanewmechanismregulatingadiposetissueinflammationinobesityandasanoveltherapeuticstrategyinthemetabolicsyndrome AT soniabrichard micrornasasanewmechanismregulatingadiposetissueinflammationinobesityandasanoveltherapeuticstrategyinthemetabolicsyndrome AT xuyi micrornasasanewmechanismregulatingadiposetissueinflammationinobesityandasanoveltherapeuticstrategyinthemetabolicsyndrome AT qifuli micrornasasanewmechanismregulatingadiposetissueinflammationinobesityandasanoveltherapeuticstrategyinthemetabolicsyndrome |